BACKGROUND: The recurrence rate for colorectal liver metastases after repeat hepatic resection is high, and selection criteria for repeat hepatectomy are still controversial. METHODS: Clinical data of patients undergoing repeat hepatectomy for metastatic colon cancer were reviewed retrospectively and compared with those of initial hepatectomy and other treatments to determine criteria for repeat hepatectomy and to confirm its efficacy. RESULTS: For 22 patients who underwent repeat hepatectomy, no mortality and an 18% morbidity rate were observed. The 3-year survival rate after repeat hepatectomy was 49%. The only poor prognostic factor after repeat hepatectomy was a serum carcinoembryonic antigen level greater than 50 ng/mL before initial hepatectomy. The prognosis for patients who underwent repeat hepatectomy and had shown high carcinoembryonic antigen levels before initial hepatectomy was approximately equal to that for the patients who received systemic chemotherapy or hepatic arterial infusion for unresectable tumors in the remnant liver. CONCLUSION: Repeat hepatectomy for colorectal liver metastases can be performed safely and appears to be as effective as initial hepatectomy. However, for patients with a carcinoembryonic antigen level greater than 50 ng/mL before the initial hepatectomy, repeat hepatic resection alone may not be as effective, and a new strategy is needed.
BACKGROUND: The recurrence rate for colorectal liver metastases after repeat hepatic resection is high, and selection criteria for repeat hepatectomy are still controversial. METHODS: Clinical data of patients undergoing repeat hepatectomy for metastatic colon cancer were reviewed retrospectively and compared with those of initial hepatectomy and other treatments to determine criteria for repeat hepatectomy and to confirm its efficacy. RESULTS: For 22 patients who underwent repeat hepatectomy, no mortality and an 18% morbidity rate were observed. The 3-year survival rate after repeat hepatectomy was 49%. The only poor prognostic factor after repeat hepatectomy was a serum carcinoembryonic antigen level greater than 50 ng/mL before initial hepatectomy. The prognosis for patients who underwent repeat hepatectomy and had shown high carcinoembryonic antigen levels before initial hepatectomy was approximately equal to that for the patients who received systemic chemotherapy or hepatic arterial infusion for unresectable tumors in the remnant liver. CONCLUSION: Repeat hepatectomy for colorectal liver metastases can be performed safely and appears to be as effective as initial hepatectomy. However, for patients with a carcinoembryonic antigen level greater than 50 ng/mL before the initial hepatectomy, repeat hepatic resection alone may not be as effective, and a new strategy is needed.
Authors: Jean M Butte; Mithat Gönen; Peter J Allen; T Peter Kingham; Constantinos T Sofocleous; Ronald P DeMatteo; Yuman Fong; Nancy E Kemeny; William R Jarnagin; Michael I D'Angelica Journal: Ann Surg Oncol Date: 2015-01-09 Impact factor: 5.344
Authors: Vincent W T Lam; Tony Pang; Jerome M Laurence; Emma Johnston; Michael J Hollands; Henry C C Pleass; Arthur J Richardson Journal: J Gastrointest Surg Date: 2013-03-23 Impact factor: 3.452
Authors: Marcus C B Tan; Jean M Butte; Mithat Gonen; Nancy Kemeny; Yuman Fong; Peter J Allen; T Peter Kingham; Ronald P Dematteo; William R Jarnagin; Michael I D'Angelica Journal: HPB (Oxford) Date: 2013-06-19 Impact factor: 3.647
Authors: Daria Zorzi; John T Mullen; Eddie K Abdalla; Timothy M Pawlik; Axel Andres; Andrea Muratore; Steven A Curley; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey Journal: J Gastrointest Surg Date: 2006-01 Impact factor: 3.267
Authors: V K H Wong; H Z Malik; Z Z R Hamady; A Al-Mukhtar; D Gomez; K R Prasad; G J Toogood; J P A Lodge Journal: Br J Cancer Date: 2007-01-09 Impact factor: 7.640
Authors: Nikol Snoeren; Sander R van Hooff; Rene Adam; Richard van Hillegersberg; Emile E Voest; Catherine Guettier; Paul J van Diest; Maarten W Nijkamp; Mariel O Brok; Dik van Leenen; Marian J A Groot Koerkamp; Frank C P Holstege; Inne H M Borel Rinkes Journal: PLoS One Date: 2012-11-21 Impact factor: 3.240